Rapid Weight Loss on a GLP-1 Agonist With Declining Strength and Low Intake
Derek, 51, is 178 cm tall and weighed 118 kg (BMI 37.2) eight months ago, when his physician started semaglutide at 1.7 mg weekly; he also takes metformin 500 mg twice daily. He now weighs 100 kg (BMI 31.6). He reports persistent nausea for two days after each injection, eats "barely 900 kcal" because food repels him, and estimates 45 g of protein daily. He does no resistance training and walks 20 minutes three times weekly. He mentions constant fatigue, hair shedding in the shower, and that he has started sitting down to put on his shoes because his legs feel weak. Grip strength today is 34 kg, down from 41 kg at intake, and his 30-second chair stand is 11, down from 15. He is pleased with the weight loss and wants to continue until he reaches 80 kg.
1. Which findings demand action, and which actions fall inside versus outside your scope as a weight-loss specialist?
Read the worked answer
Red flags. Intake near 900 kcal, protein at 45 g, a 7 kg grip-strength drop, a four-repetition decline in chair stands, hair shedding, fatigue, and nausea severe enough to suppress eating. Together these suggest inadequate energy and protein intake with likely lean-mass loss, plus possible micronutrient deficiency.
Inside scope. Document objectively - weight trend, estimated intake, protein servings per day, grip and chair-stand values, symptom frequency - and communicate these to the prescriber. Screen mood with a brief tool such as the PHQ-2, ask about disordered eating and alcohol, and coach nutrition and training. Educate him on why the findings matter.
Outside scope. Do not advise a dose change, do not diagnose the cause of nausea or hair loss, and do not order labs. Refer to the prescriber for evaluation (iron, B12, thyroid, and medication tolerance are prescriber decisions) and to a registered dietitian for a formal nutrition assessment. His stated goal of 80 kg means another 20 kg on an already inadequate intake - raise this with the care team rather than simply supporting it.
Frame the referral as support for his goal, not a warning that he is failing.
2. Design his next 8 weeks. What is the priority, and how do you program nutrition and exercise around nausea?
Read the worked answer
The priority is no longer the deficit - the medication is producing it. The job is protecting lean mass and function.
Nutrition. Set protein at 1.2–1.6 g/kg of current body weight, roughly 120–140 g/day, using goal weight only as a cross-check. Aim for 4–5 small feedings of 25–35 g protein, protein first at each, with shakes or Greek yogurt on low-appetite days. Front-load calories and fluids on the days appetite is best (often before the injection), and use bland, cool, low-odor foods during the nausea window. Add hydration and fiber. Emphasize adequate total energy, not restriction.
Training. Resistance training 2–3 times weekly, 2–3 sets of 8–12 reps on machines or supported patterns, prioritizing legs, hips, and back; progress load when he can complete the top of the rep range with good form. Keep walking and build toward 6,000–8,000 steps daily. Avoid adding intense cardio that further suppresses appetite.
Monitoring. Re-measure grip, chair stand, waist, and weight every 4 weeks. A stable or improving chair stand and grip while weight declines is the success signal; continued strength loss warrants another conversation with the prescriber.
3. How do you handle the conversation about his 80 kg target and the pace of loss?
Read the worked answer
Start by validating the achievement - 18 kg in 8 months has likely improved his blood pressure, glucose, and joint load, and he deserves to hear that.
Then reframe the target. Ask what 80 kg is meant to deliver: likely appearance, mobility, and long-term health. Point out that the scale cannot distinguish fat from muscle, and that rapid loss with 45 g of protein and no resistance training typically means a meaningful share of the loss is lean tissue - consistent with his grip and chair-stand declines. Losing more weight the same way would compound that.
Offer a revised scoreboard: waist circumference, body composition if available, grip strength, chair-stand performance, steps, and protein consistency. Suggest a provisional body-weight range rather than a single number, and note that a slower final phase protects function and makes maintenance more likely.
Finally, connect it to maintenance. Ask what he plans to eat when the medication stops or the dose changes, and position resistance training and protein habits now as the bridge. Keep the tone collaborative: "Here is what the data suggests we protect while you keep losing." Document the conversation and his response.